Varian Medical Systems

Varian Medical Systems, headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

Varian Medical Systems sees its Relative Strength Rating enter the elite 90-plus level.
The post Stock Upgrades: Varian Medical Systems Shows Rising Relative Strength appeared first on Investor's Business Daily.

Stock Upgrades: Varian Medical Systems Shows Rising Relative Strength

NEW YORK, Aug. 4, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Varian Medical Systems, Inc.

STOCKHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Varian Medical Systems, Inc. - VAR

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Varian Medical Systems, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Varian Medical Systems, Inc.

Siemens Healthineers AG

Why Varian Medical Systems Stock Surged Today

NEW YORK--(BUSINESS WIRE)-- #Acquisition--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Varian Medical Systems, Inc.

VARIAN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of VAR and Encourages Investors to Contact the Firm

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Varian Medical Systems, Inc.

Varian Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Varian Medical Systems, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Varian Medical Systems, Inc. (NYSE: VAR) and its board of directors concerning the proposed acquisition of the company by Siemens Healthineers AG.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Varian Medical Systems, Inc.

Siemens Healthineers plans a two-step capital increase to raise 7.5 billion euros ($8.80 billion) via share placements to help finance its acquisition of Varian Medical Systems , sources close to the matter said on Monday.

Siemens Healthineers plans two-step 7.5 billion euro capital hike for Varian acquisition: sources

New York, New York--(Newsfile Corp. - August 3, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/7091/60956_7645439484542bdb_001full.jpgTo: All Persons or Entities

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Varian Medical Systems, Inc. to Siemens Healthineers AG

Varian's (VAR) solid Oncology platform is expected to have driven fiscal third-quarter performance.

Varian (VAR) to Report Q3 Earnings: What's in the Offing?

Varian Medical Systems, Inc (NYSE: VAR) announced Sunday that Siemens Healthineers AG (OTC: SMMNY) would purchase it in an all-cash transaction valued at $16.4 billion.

Germany's Siemens Healthineers To Acquire Varian Medical In $16.4B All-Cash Deal

SAN DIEGO, Aug. 2, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Varian Medical Systems, Inc.

(VAR) Alert: Johnson Fistel Investigates Proposed Sale of Varian; Is $177.50 a Fair Price?

German health group Siemens Healthineers said on Sunday it would acquire Varian Medical Systems Inc in a deal that values the U.S. maker of devices and software fortreating cancer at $16.4 billion.

Siemens Healthineers to acquire Varian for $16.4 billion

PALO ALTO, Calif., Aug. 2, 2020 /PRNewswire/ -- Third Quarter 2020 Summary Operating performance reflects a full quarter of COVID-19 impact across all geographies Oncology Systems gross orders down 14% in dollars and in constant currency in the quarter; trailing twelve months gross orders.

Varian Reports Results for Third Quarter of Fiscal Year 2020

PALO ALTO, Calif., Aug. 2, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG (Frankfurt: SHL) in an all-cash transaction valued at $16.4 billion on a fully diluted basis.

Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction

German group Siemens Healthineers AG is in advanced talks to purchase Varian Medical Systems Inc , a maker of devices and software for treating cancer, in a deal that will value the medical device maker at about $15 billion, Bloomberg News reported late on Saturday.

Siemens Healthineers in advanced talks to buy Varian for $15 billion: Bloomberg News

PALO ALTO, Calif., July 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its third quarter fiscal year 2020 earnings release date.

Varian Announces Third Quarter Fiscal Year 2020 Earnings Release Date

PALO ALTO, Calif. and BEIJING, July 6, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Award for Radiotherapy Products" in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for the third year in a row. Varian...

Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China For Third Year In A Row

Varian Medical stock has rallied around 34% over recent weeks (vs. about a 36% gain in the S&P 500) to its current level of $120, after falling to a low of $90 in late March as a rapid increase in the number of Covid-19 cases outside China resulted in heightened fears of an imminent global economic.

Varian Down 18% From 2020 Peak, 15% Gain Possible Post-Covid?

PALO ALTO, Calif., June 1, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced two executive appointments. Michael Hutchinson has joined the company as Senior Vice President, Chief Legal Officer following the previously communicated retirement plans of John Kuo. The company also...

Varian Appoints Michael Hutchinson to Senior Vice President, Chief Legal Officer, and Francis R. Facchini, M.D.

PALO ALTO, Calif., May 29, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Dow Wilson, Chief Executive Officer, J. Michael Bruff, Chief Financial Officer, and Anshul Maheshwari, Vice President, Investor Relations and Treasurer will participate in a virtual fireside chat at...

Varian to Participate in Goldman Sachs Global Virtual Healthcare Conference

PALO ALTO, Calif., May 27, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that J. Michael Bruff, Chief Financial Officer, Chris Toth, President, Varian Oncology Systems, and Anshul Maheshwari, Vice President, Investor Relations and Treasurer will participate in a virtual fireside...

Varian to Participate in Jefferies Virtual Healthcare Conference

This development, which is in response to the challenges brought on by the pandemic, is expected to boost Varian's (VAR) Oncology segment.

Varian (VAR) Unveils New Features for Noona Software

PALO ALTO, Calif., May 21, 2020 /PRNewswire/ -- In response to the significant healthcare delivery changes brought on by COVID-19, Varian (NYSE: VAR) has launched new capabilities for its Noona® software application, a powerful tool designed to engage cancer patients in their care for...

Varian Launches New Noona® Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare

PALO ALTO, Calif., May 18, 2020 /PRNewswire/ -- As further evidence of the strong industry response to a potential new paradigm in the treatment of cancer, Varian (NYSE: VAR) today announced that Proton Therapy Pte., Ltd. (http://www.proton.sg/) in Singapore has joined the FlashForward™...

News for Varian Medical Systems Stock (VAR)